Navigation Links
Zevacor Molecular to Open Only Commercial 70 MeV Cyclotron Dedicated to Medical Use in the United States
Date:9/25/2013

INDIANAPOLIS, Sept. 25, 2013 /PRNewswire/ -- The Zevacor Molecular Board of Directors announced approval of funding to purchase the only 70 MeV commercial cyclotron dedicated to medical use in the United States. Zevacor Molecular is engaged with various vendors and will award the contract within 30 days. The 70 MeV cyclotron, expected to be operational in the fall of 2016, will expand Zevacor Molecular's pharmaceutical line.

Zevacor Molecular, an independently owned healthcare firm that manufactures and distributes PET and SPECT radiopharmaceuticals, has committed to this multi-million dollar project to introduce a commercial medical 70 MeV Cyclotron in order to stabilize the domestic supply of medical isotopes needed to diagnose and treat critical illnesses.

"Medical isotopes are critical to early and accurate diagnosis of cancer, heart disease and a number of other life threatening diseases," said Zevacor Molecular Executive Vice President and Chief Operating Officer John Zehner. "In the past, the supply of medical isotopes has not been continuous, making it difficult to offer these diagnostics and therapeutics. This investment will allow us to provide year round production of medically necessary isotopes for patients."

Zevacor Molecular was established in 2012. Zevacor's efforts come at a time when there is little certainty of supply in the market for medical isotopes. The 70 MeV will have the ability to supply patients with medically necessary isotopes used for diagnostic imaging and therapies within oncology, neurology and cardiology. Although the project is focused on Strontium (Sr-82), which is the raw material for Rubidium (Rb-82) generators, it also opens up several research isotopes currently not widely available in the United States such as Copper-67 which is a therapeutic for treating cancer.


'/>"/>
SOURCE Zevacor Molecular
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
4. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
5. The 2012 US Molecular Diagnostics Market
6. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
7. BSGI Molecular Breast Imaging Proves Equivalent to MRI in Breast Cancer Patient Management
8. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
9. Science Translational Medicine and the DMM Global Foundation Announce Days of Molecular Medicine 2012 "The Translational Science of Rare Diseases: From Rare To Care."
10. IBA Molecular, Piramal Imaging Sign Agreement for New F-18 Amyloid Imaging Agent
11. New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces that a ... catalogue: North America Aesthetic Lasers and ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North America ... 2020 Summary GlobalData,s new report, "North ... to 2020", provides key market data on the ...
(Date:8/28/2014)... WILMINGTON, Del. , Aug. 28, 2014  Rigrodsky & Long, ... shares of Lannett Company, Inc. (NYSE: LCI )? , ... between September 10, 2013 and July 16, 2014, inclusive? , ... Inc.? , Do you want to discuss your rights? ... former Special Assistant United States Attorney, Timothy J. MacFall , ...
(Date:8/28/2014)... NEW YORK , Aug. 28, ... a new market research report is ... Testing Laboratories, Safety and Compliance Services ... Metrics and Revenue Forecasts to 2021, ... http://www.reportlinker.com/p02347353/Testing-Laboratories-Safety-and-Compliance-Services-Industry-US--Analytics-Extensive-Financial-Benchmarks-Metrics-and-Revenue-Forecasts-to-2021-NAIC-541380 .html Testing ...
Breaking Medicine Technology:North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
... Ariadne , a leader in bioinformatics software and ... renewed their license for Pathway Studio ® Enterprise ... and Ariadne MedScan® text processing technology for site-wide use. ... cancer disease pathways and develop mechanistic rationale for disease ...
... Grifols, a global healthcare company and biopharmaceutical manufacturer based ... from the US Food and Drug Administration (FDA) for ... Factor Complex (Human) indicating that certain manufacturing steps have ... TSE agent that is a model for variant Creutzfeldt ...
Cached Medicine Technology:Site-wide License for Ariadne's Pathway Studio Renewed by NCI 2FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD 2FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD 3FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD 4
(Date:8/28/2014)... (PRWEB) August 28, 2014 Millennium Treatment Group ... America is extremely large, and Millennium Treatment Group is working ... treatment that they need. , According to the National ... than 21 million Americans could have benefited from treatment for ... people received help. This means that there is a large ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 American adults ... industry on the Internet will now have a simpler ... company. In one click this year, some of the ... http://quotespros.com/life-insurance.html . , The promoted plans that ... Pros finder tool represent popular policies. The term, guaranteed ...
(Date:8/28/2014)... plans its exit strategy from the war, now may be ... health care to veterans, says a Perspective piece in the ... go on doing more of the same is to fail ... and population structure pose in the longer run," said William ... Practice, and David Auerbach, from the RAND Corporation, in the ...
(Date:8/28/2014)... Greenwich, CT and Ann Arbor, MI (PRWEB) August 28, ... I portfolio company and the nation’s leading intraoperative neurophysiology ... Gecsey, President and CFO, to the position of Chief ... 2010 as CFO, was promoted to President and CFO ... Biotronic’s continued growth and success. , “Bill’s efforts ...
(Date:8/28/2014)... August 28, 2014 Kirklyn Smith, an office ... may be a new world’s record by walking 5,000 miles ... we are constantly amazed by the thousands of individual stories ... just seem to stand out more than the others. , ... hour step count which tallies a range of 54,823 steps ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Works to Close Treatment Gap 2Health News:Best Life Insurance Rates for 2014 Now Promoted at Insurer Website 2Health News:A VA exit strategy 2Health News:Biotronic NeuroNetwork Announces the Promotion of Bill Gecsey to CEO 2Health News:There are many reasons why Americans' exercise levels have declined - Meet an executive that refuses to sit still with his TrekDesk Treadmill Desk even in a sedentary job 2
... in which health care providers are rewarded with more ... in the UK and Australia. The approach has ... Medicare and Medicaid Services (CMS), which is responsible for ... the US is slated for 2013, when hospitals will ...
... strategy for women who can potentially benefit from repeat mammography ... single intervention that is best, according to a study published ... Cancer Institute. Regular mammography screening has been ... ages of 50 and 74 by approximately 23%. However, until ...
... from the Action to Control Cardiovascular Risk in Diabetes ... kind to determine whether intensive blood glucose (sugar) control ... results show that the benefits of intensive therapy need ... cardiovascular disease-related death, increased weight gain, and high risk ...
... ... winning products were celebrated in a ceremony marked by an announcement of the competition,s gold ... the category of general hospital devices and therapeutic products. , ... Gainesville, FL (Vocus) June 29, 2010 -- Earlier this year, ...
... ... Web site for parents, has launched KidsDoc Symptom Checker, a new online tool to help ... , ... 29, 2010 -- What should you do if your child develops a fever, cough, vomiting, ...
... insurance, low-income women had lower rates of mammography screening ... likelihood of screening. "Health insurance is a ... a sufficient condition," said Nasar Ahmed, Ph.D., chair of ... Public Health and Social Work at Florida International University. ...
Cached Medicine News:Health News:Pay-for-performance for hospitals 2Health News:Interventions to promote repeat breast cancer screening with mammography 2Health News:Intensively lowering glucose: Possible benefits must be weighed against risks 2Health News:Intensively lowering glucose: Possible benefits must be weighed against risks 3Health News:Xhale Innovation's HyGreen Hand Hygiene System Brings Home the Gold 2Health News:AAP Offers New Online Pediatric Symptom Checker on HealthyChildren.org 2Health News:Counseling increased mammography use among low-income women with health insurance 2
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products. Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000), BinaxNow E.coli...
... For the qualitative differential ... (P.f) antigen and an antigen ... four species of malaria:plasmodium falciparum ... ovale (P.o) and Plasmodium malariae ...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
Medicine Products: